Navigation Links
Former French Prime Minister Jean-Pierre Raffarin Visits Sundia
Date:1/26/2010

SHANGHAI, Jan. 26 /PRNewswire-Asia/ -- Sundia MediTech Company, Ltd., a leading pharmaceutical R&D outsourcing Service Company in China, announced that a French delegation led by former French Prime Minster Jean-Pierre Raffarin visited Sundia on January 22, 2010. M.Raffarin, currently President of Foundation Prospective et Innovation, was accompanied by Dr. Serge Feneuille and Mr. Erwan Davoux of the foundation, and Dr. Jean-Jacques PIERRAT, Scientific Consul of General Consulate of France in Shanghai and other delegates.

At Sundia, Dr. Xiaochuan Wang, CEO of Sundia, welcomed the delegation and thanked Mr. Raffarin for his actions for the promotion of Sino-French friendship and for visiting Sundia. She gave them a review about the growth of Sundia. The delegation also spent time visiting Sundia's R&D facilities and meeting Sundia's senior management team. They discussed about the Sino- French Collaborations on Science and Technology. Dr. Jean Christophe Poupon, Senior Scientist from France, and who has worked at Sundia for more than three years, was also invited to participate the meeting.

Raffarin has visited China many times and knows China very well. He said: "France has always cherished its friendship with China. We want to have more Chinese companies to invest in France in the future." At the end of the visit, he conveyed his deep appreciation and best wishes to Sundia.

SOURCE Sundia MediTech Company, Ltd.


'/>"/>
SOURCE Sundia MediTech Company, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 12, 2016  PTC Therapeutics, Inc. (NASDAQ: ... (Strategies to Realize Innovation, Vision and Empowerment) grant ... provides funds to patient advocacy organizations to develop ... contributions to the rare disease community by increasing ... patient advocates. Mary Frances Harmon ...
(Date:2/11/2016)... AUSTIN, Texas , Feb. 11, 2016  Vermillion, ... focused on gynecologic disease, today announced the formation of ... --> --> Pelvic ... in both diagnosis and management. Once pregnancy is ruled ... fallopian tubes and ovaries, advanced endometriosis, benign ovarian tumors ...
(Date:2/11/2016)... , Feb. 11, 2016  Wellcentive today ... Portland, Oregon -based community care ... provide population health analytics, quality reporting and care ... FamilyCare strengthen its team of quality managers, analysts ... to the provider groups serving FamilyCare members. ...
(Date:2/11/2016)... 11, 2016   BioInformant announces the February ... Research Products, Opportunities, Tools, and Technologies – Market Size, ... The first and ... cell industry, BioInformant has more than a decade of ... market, by stem cell type. This powerful 175 page ...
Breaking Biology Technology:
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first day ... announced plans to develop a first of its kind ... of IBM Watson. In the first application of ... (NYSE: IBM ), and Welltok will create a ... assessments with cognitive analytics, delivered on Welltok,s health optimization ...
(Date:1/25/2016)... Jan. 25, 2016   Unisys Corporation (NYSE: UIS ... F. Kennedy (JFK) International Airport, New York City ... identify imposters attempting to enter the United States ... them. pilot testing of the system at Dulles ... terminals at JFK during January 2016. --> pilot testing ...
(Date:1/21/2016)... January 21, 2016 ... new market research report "Emotion Detection and Recognition Market by ... Tools (Facial Expression, Voice Recognition and Others), Services, ... forecast to 2020", published by MarketsandMarkets, the global ... reach USD 22.65 Billion by 2020, at a ...
Breaking Biology News(10 mins):